# Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

> **NCT02209701** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 3 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** Porfiromycin

## Key facts

- **NCT ID:** NCT02209701
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-12
- **Primary completion:** 2000-07
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2014-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209701, "Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02209701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*